Scott M. Coiante - SVP, Chief Financial Officer at Lexicon Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Financial Officer
Stock Symbol
LXRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Scott M. Coiante since 4/23/2024

Holdings reported by Scott M. Coiante for Lexicon Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 481K $322K $0.67 Feb 13, 2025 Direct Common Stock
Stock Option (Right to Buy) 721K Feb 13, 2025 Direct Common Stock

Transactions reported by Scott M. Coiante for Lexicon Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.